Posted in | News | Nanomaterials

Nobel Prize Winner Endorses Aledia’s Nanowire LED Technology

Prof. Hiroshi Amano, a member of Aledia’s Scientific Advisory Board, was awarded the Nobel Prize in Physics, alongside Shuji Nakamura and Isamu Akasaki for their roles in inventing the blue light emitting diode (LED), that has revolutionized the lighting and display worlds.

Prof. Amano received the news while working with Aledia’s technical team in Grenoble, where Aledia is based.

In a speech to a large gathering of scientists after the winners were announced, Prof. Amano pointed out the huge impact on energy savings that will be made possible by LEDs, as well as the bright future of LED technology.

“Nanowire LEDs can be a big step forward, they are the best structures for the next generation of LEDs,” Prof. Amano said. “In particular, Aledia’s nanowire technology has a very big potential to make a step-change improvement in LED technology.”

Giorgio Anania, CEO of Aledia, said: “We are thrilled about the recognition given by the Nobel committee to Prof. Amano and his colleagues. This prize recognizes a man with immense technology expertise and a technology that is having a huge impact on all people in the world, a revolution that is just beginning. At Aledia, Prof. Amano is helping us develop the next generation of LEDs, a new 3D technology able to reduce substantially the overall cost, making them affordable to everyone, and facilitating their integration with electronics to give smart lighting and new concepts for microdisplays."

Aledia is a spinout of the CEA in Grenoble, one of Europe’s leading microelectronics research laboratories. Founded in 2011, the company has received funding from leading European and U.S. venture capital firms.

Source: http://www.aledia.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.